Over four months ago, Elizabeth Carter and Leigh Purvis, researchers at AARP’s Pubic Policy Institute, released a study taking a look at the appropriate use and cost of the long-term prescribing dementia drugs.  They concluded by urging health care providers to “regularly assess patients and their drug regimens to ensure these regimens remain appropriate reflecting…

Read More
Prescribing Dementia Drugs

  Seventy percent of elderly dementia patients prescribed dementia drugs are on them long-term despite the lack of evidence that they provide any benefit beyond one year, says a new report released by the AARP Public Policy Institute.  Reducing overuse of dementia drugs could result in substantial savings, estimating $20,000 per patient, for patients insurers.…

Read More